Novel radiotracer demonstrates high diagnostic efficacy for obese patients with coronary artery disease
Chicago, Illinois (Embargoed until 2:15 p.m. CDT, Tuesday, June 27, 2023)—A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients...